Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial-Reference-Cited by-同舟云学术

Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial

Published:2020-12-08 Issue:2 Volume:56 Page:145-154
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Strik Anne S.¹^ORCID,Löwenberg Mark¹,Mould Diane R.²^ORCID,Berends Sophie E.³^ORCID,Ponsioen Cyriel I.¹,van den Brande Jan M. H.⁴,Jansen Jeroen M.⁵,Hoekman Daniël R.¹,Brandse Johannan F.¹,Duijvestein Marjolijn¹,Gecse Krisztina B.¹,de Vries Annick⁶,Mathôt Ron A.³,D’Haens Geert R.¹

Affiliation:

1. Department of Gastroenterology and Hepatology, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands

2. Projections Research Inc., Phoenixville, PA, USA

3. Department of Hospital Pharmacy, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands

4. Department of Gastroenterology and Hepatology, Tergooi Hospital, Hilversum, The Netherlands

5. Department of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands

6. Sanquin Diagnostic Services, Amsterdam, The Netherlands

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2020.1856405

Reference41 articles.

1. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

2. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

3. Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis

4. American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease

5. Accelerated Clearance of Infliximab is Associated With Treatment Failure in Patients With Corticosteroid-Refractory Acute Ulcerative Colitis

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Targets Should Influence Choice of Infliximab Dose Intensification Strategy in Inflammatory Bowel Disease: A Pharmacokinetic Simulation Study;BioDrugs;2024-08-22

2. Model-informed precision dosing: State of the art and future perspectives;Advanced Drug Delivery Reviews;2024-08

3. The potential for therapeutic drug monitoring of belatacept and other biologicals in solid organ transplantation;British Journal of Clinical Pharmacology;2024-07-26

4. Proactive Therapeutic Drug Monitoring Is Associated With Increased Drug Persistence in Patients With Inflammatory Bowel Disease Treated With Intravenous Vedolizumab;Inflammatory Bowel Diseases;2024-07-02

5. Is infliximab therapy currently relevant in patients with inflammatory bowel diseases? (review);Koloproktologia;2024-06-21